{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:06:33Z","timestamp":1785564393347,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ymgme.2023.107631","type":"journal-article","created":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T17:33:49Z","timestamp":1688924029000},"page":"107631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency"],"prefix":"10.1016","volume":"139","author":[{"given":"Eline C.B.","family":"Eskes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.C.","family":"van der Lienden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sjouke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion M.M.G.","family":"Brands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107631_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107631_bb0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","article-title":"Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients","volume":"107","author":"Hollak","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13023-021-01842-0","article-title":"Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation","volume":"16","author":"McGovern","year":"2021","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10545-012-9503-0","article-title":"Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B","volume":"36","author":"Wasserstein","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107631_bb0030","author":"EMA) EMA"},{"key":"10.1016\/j.ymgme.2023.107631_bb0035","author":"(FDA) FaDA"},{"key":"10.1016\/j.ymgme.2023.107631_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2022.03.001","article-title":"The diagnosis and management of Gaucher disease in pediatric patients: where do we go from here?","volume":"136","author":"Weinreb","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2020.02.002","article-title":"Biochemical and imaging parameters in acid sphingomyelinase deficiency: potential utility as biomarkers","volume":"130","author":"Eskes","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107631_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2020.06.008","article-title":"Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy","volume":"131","author":"Jones","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107631_bb0060","series-title":"Fabry Disease: Perspectives from 5 Years of FOS. Oxford","article-title":"Biomarkers in lysosomal storage diseases","author":"Cox","year":"2006"},{"issue":"5","key":"10.1016\/j.ymgme.2023.107631_bb0065","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.ymgme.2023.107631_bb0070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10545-014-9711-x","article-title":"Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy","volume":"37","author":"van Dussen","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107631_bb0075","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.ymgme.2023.107631_bb0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/2211-5463.12078","article-title":"Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models","volume":"6","author":"Kramer","year":"2016","journal-title":"FEBS Open Bio."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010066","article-title":"An emerging biomarker for lysosomal dysfunction in macrophages","volume":"20","author":"van der Lienden","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2023.107631_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674739","article-title":"The role of GPNMB in inflammation","volume":"12","author":"Saade","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107631_bb0095","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/jcb.25394","article-title":"Macrophage-associated osteoactivin\/GPNMB mediates mesenchymal stem cell survival, proliferation, and migration via a CD44-dependent mechanism","volume":"117","author":"Yu","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jid.2017.08.034","article-title":"Glycoprotein nonmelanoma clone B regulates the crosstalk between macrophages and mesenchymal stem cells toward wound repair","volume":"138","author":"Yu","year":"2018","journal-title":"J Invest Dermatol."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107631_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012093","article-title":"ADAM10 releases a soluble form of the GPNMB\/Osteoactivin extracellular domain with angiogenic properties","volume":"5","author":"Rose","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0110","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/s41598-022-10522-3","article-title":"Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells","volume":"12","author":"Suda","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2023.107631_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2016.12.002","article-title":"Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease","volume":"68","author":"Murugesan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147208","article-title":"Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease","volume":"11","author":"Marques","year":"2016","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.ymgme.2023.107631_bb0125","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/hmg\/ddab194","article-title":"Transcriptome of HPbetaCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics","volume":"30","author":"Rodriguez-Gil","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2023.107631_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellimm.2017.03.006","article-title":"Glycoprotein non-metastatic melanoma protein b (Gpnmb) is highly expressed in macrophages of acute injured kidney and promotes M2 macrophages polarization","volume":"316","author":"Zhou","year":"2017","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107631_bb0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2007.02.042","article-title":"Monitoring of Gaucher patients with a novel chitotriosidase assay","volume":"381","author":"Schoonhoven","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107631_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2017.12.431","article-title":"Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature","volume":"123","author":"Voorink-Moret","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107631_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010452","article-title":"Intracerebroventricular treatment with 2-hydroxypropyl-beta-cyclodextrin decreased cerebellar and hepatic glycoprotein nonmetastatic melanoma protein B (GPNMB) expression in Niemann-Pick disease type C model mice","volume":"22","author":"Fukaura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2023.107631_bb0155","article-title":"Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease","volume":"29","author":"Kleytman","year":"2021","journal-title":"Mol Genet Metab Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:54:18Z","timestamp":1761090858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1096719223002615"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107631","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107631"}}